• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑海绵状血管畸形血管特征的超微结构分析

Ultrastructural analysis of vascular features in cerebral cavernous malformations.

作者信息

Tanriover Gamze, Sozen Berna, Seker Askin, Kilic Turker, Gunel Murat, Demir Necdet

机构信息

Department of Histology and Embryology, Akdeniz University, School of Medicine, Antalya 07070, Turkey.

出版信息

Clin Neurol Neurosurg. 2013 Apr;115(4):438-44. doi: 10.1016/j.clineuro.2012.06.023. Epub 2012 Jul 7.

DOI:10.1016/j.clineuro.2012.06.023
PMID:22776801
Abstract

OBJECTIVE

Investigation of the structure of vascular malformations highlights the pathogenic mechanisms underlying their clinical behavior. One of the vascular malformations is called cerebral cavernous malformation (CCM). However, the ultrastructural features of the vascular malformations are not defined in detail.

METHODS

We aimed to investigate the ultrastructural features of CCMs using transmission (TEM), scanning (SEM) electron microscopy, and also immunohistochemistry methods with antibodies against CCM proteins such as CCM2 and CCM3. CCM tissues (n=6) microsurgically excised from patients for conventional indications.

RESULTS

CCM2 and CCM3 were strongly detected in the vascular endothelium. However, there was a very weak immunostaining in stroma. SEM observations revealed that there were ruptures and damages in the luminal endothelium, possibly due to the damage of intercellular junctions. TEM observations also showed a few ruptures and detachments between the endothelium and basal lamina as observed with partially damages and disconnections. The architecture of pericytes showed protrusions and shrinkages. Our results suggest that the thin vessel walls of CCMs were lacking of subendothelial support and intact basal lamina underlying the endothelial cells.

CONCLUSION

This study is so far the first study attempting to show human CCM lesions with SEM. We believe that an understanding of the ultrastructural features of these lesions by light and electron microscopy techniques would help to understand the pathology of these diseases.

摘要

目的

对血管畸形结构的研究突出了其临床行为背后的致病机制。其中一种血管畸形称为脑海绵状畸形(CCM)。然而,血管畸形的超微结构特征尚未得到详细界定。

方法

我们旨在使用透射电子显微镜(TEM)、扫描电子显微镜(SEM)以及针对CCM蛋白(如CCM2和CCM3)的抗体进行免疫组织化学方法来研究CCM的超微结构特征。CCM组织(n = 6)是从患者身上通过显微手术切除的,用于常规适应症。

结果

在血管内皮中强烈检测到CCM2和CCM3。然而,在基质中免疫染色非常弱。SEM观察显示管腔内内皮存在破裂和损伤,可能是由于细胞间连接的破坏。TEM观察还显示,在内皮细胞与基膜之间存在一些破裂和分离,观察到部分损伤和断开。周细胞的结构显示出突起和收缩。我们的结果表明,CCM的薄壁血管缺乏内皮下支持以及内皮细胞下方完整的基膜。

结论

本研究是迄今为止首次尝试用SEM展示人类CCM病变的研究。我们相信,通过光学和电子显微镜技术了解这些病变的超微结构特征将有助于理解这些疾病的病理学。

相似文献

1
Ultrastructural analysis of vascular features in cerebral cavernous malformations.脑海绵状血管畸形血管特征的超微结构分析
Clin Neurol Neurosurg. 2013 Apr;115(4):438-44. doi: 10.1016/j.clineuro.2012.06.023. Epub 2012 Jul 7.
2
Differential angiogenesis function of CCM2 and CCM3 in cerebral cavernous malformations.CCM2 和 CCM3 在脑动静脉畸形中的差异血管生成功能。
Neurosurg Focus. 2010 Sep;29(3):E1. doi: 10.3171/2010.5.FOCUS1090.
3
Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.脑海绵状血管畸形患者中的新型CCM1、CCM2和CCM3突变:CCM2中的框内缺失可阻止CCM1/CCM2/CCM3蛋白复合物的形成。
Hum Mutat. 2008 May;29(5):709-17. doi: 10.1002/humu.20712.
4
Cerebral Cavernous Malformation-1 Protein Controls DLL4-Notch3 Signaling Between the Endothelium and Pericytes.脑海绵状血管畸形-1蛋白调控内皮细胞与周细胞之间的DLL4-Notch3信号通路。
Stroke. 2015 May;46(5):1337-43. doi: 10.1161/STROKEAHA.114.007512. Epub 2015 Mar 19.
5
Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis.颅内海绵状血管畸形:从 CCM 基因到血管内皮细胞稳态。
Trends Mol Med. 2013 May;19(5):302-8. doi: 10.1016/j.molmed.2013.02.004. Epub 2013 Mar 15.
6
PDCD10, the gene mutated in cerebral cavernous malformation 3, is expressed in the neurovascular unit.PDCD10基因在脑海绵状血管畸形3型中发生突变,它在神经血管单元中表达。
Neurosurgery. 2008 Apr;62(4):930-8; discussion 938. doi: 10.1227/01.neu.0000318179.02912.ca.
7
Cerebral venous malformations have distinct genetic origin from cerebral cavernous malformations.脑静脉畸形与脑海绵状畸形有着不同的遗传起源。
Stroke. 2005 Nov;36(11):2479-80. doi: 10.1161/01.STR.0000183616.99139.d3. Epub 2005 Oct 20.
8
In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations.体外鉴定散发性脑动静脉畸形血管内皮的血管生成表型和基因型。
Neurosurgery. 2011 Sep;69(3):722-31; discussion 731-2. doi: 10.1227/NEU.0b013e318219569f.
9
CCM2 and CCM3 proteins contribute to vasculogenesis and angiogenesis in human placenta.CCM2和CCM3蛋白有助于人类胎盘的血管发生和血管生成。
Histol Histopathol. 2009 Oct;24(10):1287-94. doi: 10.14670/HH-24.1287.
10
Pathology of cavernous malformations.海绵状血管畸形的病理学
Handb Clin Neurol. 2017;143:267-277. doi: 10.1016/B978-0-444-63640-9.00025-4.

引用本文的文献

1
Persistent Activation of Endothelial Cells is Linked to Thrombosis and Inflammation in Cerebral Cavernous Malformation Disease.内皮细胞的持续激活与脑海绵状血管畸形疾病中的血栓形成和炎症相关。
bioRxiv. 2025 Jul 2:2025.06.29.662238. doi: 10.1101/2025.06.29.662238.
2
Focused ultrasound-microbubble treatment arrests the growth and formation of cerebral cavernous malformations.聚焦超声-微泡治疗可抑制脑海绵状血管畸形的生长和形成。
Nat Biomed Eng. 2025 May 13. doi: 10.1038/s41551-025-01390-z.
3
Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment.
凝集素型氧化低密度脂蛋白受体-1作为脑海绵状血管畸形治疗的潜在靶点。
Front Neurosci. 2024 Aug 21;18:1442110. doi: 10.3389/fnins.2024.1442110. eCollection 2024.
4
mTORC1 Signaling in Brain Endothelial Progenitors Contributes to CCM Pathogenesis.mTORC1 信号在脑内皮祖细胞中的作用促进 CCM 发病机制。
Circ Res. 2024 Aug 2;135(4):e94-e113. doi: 10.1161/CIRCRESAHA.123.324015. Epub 2024 Jul 3.
5
Behavioral impairments are linked to neuroinflammation in mice with Cerebral Cavernous Malformation disease.行为障碍与患有脑海绵状血管畸形疾病的小鼠的神经炎症有关。
bioRxiv. 2024 May 30:2024.05.29.596485. doi: 10.1101/2024.05.29.596485.
6
Focused Ultrasound Blood-Brain Barrier Opening Arrests the Growth and Formation of Cerebral Cavernous Malformations.聚焦超声打开血脑屏障可抑制脑海绵状血管畸形的生长和形成。
bioRxiv. 2024 Feb 4:2024.01.31.577810. doi: 10.1101/2024.01.31.577810.
7
Tunneling Nanotube: An Enticing Cell-Cell Communication in the Nervous System.隧道纳米管:神经系统中一种诱人的细胞间通讯方式。
Biology (Basel). 2023 Sep 27;12(10):1288. doi: 10.3390/biology12101288.
8
Defining the Functional Influence of Endothelial Cell-Expressed Oncogenic Activating Mutations on Vascular Morphogenesis and Capillary Assembly.定义内皮细胞表达的致癌激活突变对血管形态发生和毛细血管组装的功能影响。
Am J Pathol. 2024 Apr;194(4):574-598. doi: 10.1016/j.ajpath.2023.08.017. Epub 2023 Oct 12.
9
A novel KRIT1/CCM1 mutation accompanied by a NOTCH3 mutation in a Chinese family with multiple cerebral cavernous malformations.一个中国家族中伴有 KRIT1/CCM1 突变和 NOTCH3 突变的多发性脑海绵状血管畸形。
Neurogenetics. 2023 Apr;24(2):137-146. doi: 10.1007/s10048-023-00714-y. Epub 2023 Mar 9.
10
Multidrug-Loaded Lipid Nanoemulsions for the Combinatorial Treatment of Cerebral Cavernous Malformation Disease.用于海绵状脑畸形疾病联合治疗的多药负载脂质纳米乳剂
Biomedicines. 2023 Feb 7;11(2):480. doi: 10.3390/biomedicines11020480.